Tissue Preservation: Active Surveillance and Focal Therapy as Complimentary Strategies
作者： Juan Gómez Rivas , Mark Emberton
DOI: 10.1007/978-3-319-62710-6_19
关键词:
摘要: The following chapter contains a summary of the differences and areas overlap that exists between two main prostate preserving strategies for patients with low- to moderate-risk cancer, namely, active surveillance focal therapy.
springer.com
sci-hub.st 参考文章(28)
Jack A Schalken, Daphne Hessels, Tilly W Aalders, Lambertus A Kiemeney, Dorine W Swinkels, Rian W Roelofs, Jacques B de Kok, Gerald W Verhaegh, DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Research. ,vol. 62, pp. 2695- 2698 ,(2002)
Jérémie Haffner, Laurent Lemaitre, Philippe Puech, Georges‐Pascal Haber, Xavier Leroy, J Stephen Jones, Arnauld Villers, None, Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJUI. ,vol. 108, ,(2011) , 10.1111/J.1464-410X.2011.10112.X
Stacy Loeb, Martin G. Sanda, Dennis L. Broyles, Sanghyuk S. Shin, Chris H. Bangma, John T. Wei, Alan W. Partin, George G. Klee, Kevin M. Slawin, Leonard S. Marks, Ron H.N. van Schaik, Daniel W. Chan, Lori J. Sokoll, Amabelle B. Cruz, Isaac A. Mizrahi, William J. Catalona, The prostate health index selectively identifies clinically significant prostate cancer The Journal of Urology. ,vol. 193, pp. 1163- 1169 ,(2015) , 10.1016/J.JURO.2014.10.121
Grant D. Stewart, Leander Van Neste, Philippe Delvenne, Paul Delrée, Agnès Delga, S. Alan McNeill, Marie O'Donnell, James Clark, Wim Van Criekinge, Joseph Bigley, David J. Harrison, Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study Journal of Urology. ,vol. 189, pp. 1110- 1116 ,(2013) , 10.1016/J.JURO.2012.08.219
Neil Fleshner, Leonard G Gomella, Michael S Cookson, Antonio Finelli, Andrew Evans, Samir S Taneja, M Scott Lucia, Eric Wolford, Matthew C Somerville, Roger Rittmaster, REDEEM Study Group, Delay in the progression of low-risk prostate cancer: Rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial Contemporary Clinical Trials. ,vol. 28, pp. 763- 769 ,(2007) , 10.1016/J.CCT.2007.05.006
Hashim Uddin Ahmed, Yipeng Hu, Tim Carter, Nimalan Arumainayagam, Emilie Lecornet, Alex Freeman, David Hawkes, Dean C. Barratt, Mark Emberton, Characterizing Clinically Significant Prostate Cancer Using Template Prostate Mapping Biopsy Journal of Urology. ,vol. 186, pp. 458- 464 ,(2011) , 10.1016/J.JURO.2011.03.147
Flavie Bratan, Emilie Niaf, Christelle Melodelima, Anne Laure Chesnais, Rémi Souchon, Florence Mège-Lechevallier, Marc Colombel, Olivier Rouvière, Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study European Radiology. ,vol. 23, pp. 2019- 2029 ,(2013) , 10.1007/S00330-013-2795-0
K Robinson, J Creed, B Reguly, C Powell, R Wittock, D Klein, A Maggrah, L Klotz, R L Parr, G D Dakubo, Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay Prostate Cancer and Prostatic Diseases. ,vol. 13, pp. 126- 131 ,(2010) , 10.1038/PCAN.2009.64
Arnauld Villers, Laurent Lemaitre, Jérémie Haffner, Philippe Puech, Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance. Current Opinion in Urology. ,vol. 19, pp. 274- 282 ,(2009) , 10.1097/MOU.0B013E328329A2ED
Tineke Wolters, Rodolfo Montironi, Roberta Mazzucchelli, Marina Scarpelli, Monique J. Roobol, Roderick C.N. van den Bergh, Pim J. van Leeuwen, Robert F. Hoedemaeker, Geert J.L.H. van Leenders, Fritz H. Schröder, Theodorus H. van der Kwast, Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy The Prostate. ,vol. 72, pp. 108- 115 ,(2012) , 10.1002/PROS.21415